Traws Pharma, Inc. · NASDAQ:TRAW

Ikarian Capital, LLC reported a 9.99% stake in Traws Pharma, Inc. (Schedule 13G)

Event Dec 31, 2024 · Filed Feb 14, 2025

Ikarian Capital, LLC reported a 9.99% stake in Traws Pharma, Inc., 394,255 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G).

Stake
9.99%
Shares
394,255
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Ikarian Capital, LLC9.99%394,255
Neil Shahrestani9.99%394,255

Source

View original at SEC

Related